1 欧阳晓希,顾大勇,张少波,等. 常见肝炎病毒感染性疾病相关miRNA功能研究进展[J]. 现代生物医学进展,2016,16(8):1573-1578,1461. 2 Tang J,Fei J,Gu C,et al. The influence of B and T lymphocyte attenuator genetic variants on susceptibility to chronic hepatitis B virus infection[J]. Cell Physiol Biochem,2018,45(6):2540-2547. 3 Guidelines for the Prevention,Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization,2015. 4 许晶瑶,谢韬,姚文清,等. 发展中国家乙型肝炎流行、预防和控制[J]. 中国公共卫生,2016,32(1):31-34. 5 井立华,李文江,王佳鑫,等. 2013 年大庆市部分地区健康人群国家免疫规划疫苗抗体阳性率检测分析[J]. 实用预防医学,2015,22(5):599-601. 6 Sarmast Shooshtari MH, Makvandi M, Rasti M,et al. Evaluation of hepatitis B surface antibody and specific gamma interferon response in health care workers after vaccination[J]. Jundishapur J Microbiol,2014,8(1): e13801. 7 Luo P,Feng X,Jing W,et al. Clinical and diagnostic significance of homer1 in hepatitis B virus-induced hepatocellular carcinoma[J]. J Cancer,2018,9(4):683-689. 8 费怡,杨天,谢震宇,等.上海市浦东新区3~18岁人群乙型肝炎病毒感染及疫苗接种状况[J].上海预防医学,2017,29(11):867-871. 9 朱冬梅,蒋文,李彦勋.河南省周口市2014年1-74岁人群乙型肝炎病毒感染状况调查[J].中国疫苗和免疫,2017,23(2):152-156. 10 柴瑜,唐继海,苏颖,等.2009-2016年安徽省急性乙型病毒性肝炎监测分析[J].中国疫苗和免疫,2018,24(3):280-284. 11 唐继海,罗献伟,刘丹青,等.安徽省儿童乙型肝炎病毒感染状况及影响因素研究[J].中国疫苗和免疫,2011,17(5):404-407. 12 罗献伟,刘丹青,柴瑜,等.安徽省2011年0~6岁儿童乙型病毒性肝炎免疫水平调查[J].安徽预防医学杂志,2013,19(5):336-338. 13 石向辉,赵凌国,周洁,等.1985–2015年深圳市福田区病毒性肝炎流行特征分析[J].实用预防医学,2017,24(9):1055-1058. 14 Molu J P,Essome MCN,Monamele C G,et al. Sero-prevalence of HBsAg in naive HIV-infected patients in a rural locality of Cameroon[J].BMC Res Notes,2018,11(1):39. 15 Banatvala J E,Van Damme P,et al.Hepatitis B vaccine -do we need boosters ?[J]. J Viral Hepat,2003,10(1):1-6. 16 Banatvala J,Van Damme P,Oehen S,et al. Lifelong protection against hepatitis B:the role of vaccine immunogenicity in immune memory[J].Vaccine.2000,19(7-8):877-85. 17 Hall AJ.Boosters for hepatitis B vaccination? Need for an evidence-based policy[J]. Hepatology.2010,51(5):14856. |